SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-072999
Filing Date
2024-06-18
Accepted
2024-06-18 21:24:43
Documents
1
Period of Report
2024-06-14

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2417544-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2417544-1_4seq1.xml 4 14376
  Complete submission text file 0001104659-24-072999.txt   15821
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 780 EAST MAIN STREET C/O BIOXCEL THERAPEUTICS, INC. BRANFORD CT 06405
Business Address
Mehta Vimal (Reporting) CIK: 0001733369 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38410 | Film No.: 241053835